At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

Blog

October 25, 2017 Editorial: Progress Report: Canada’s Gilead of the North
About 2 ½ years ago, I wrote a post that made a bold prediction that Canada would have at least one fully integrated biotech company by 2025. My arguments included the increasing support from Canadian investors (particularly venture capital), aspirational Canadian management teams and the ability of specialty drugs to provide launching platforms for such companies. Following the listing of...
Read More
October 4, 2017 BLU-5937: Assessing Market Potential for the Treatment of Chronic Cough
An abridged version of the market assessment discussed in this blog is available on BELLUS Health’s website. Click here . There are three things that cannot be hidden, according to an old Yiddish proverb: coughing, poverty and love. We’ve all known someone who has difficulty carrying on a conversation due to coughing; we have all sat in the movie theater behind the man who can’t stop coughing and...
Read More

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.